The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment

Background. Chinese herbal medicine (CHM) has been used for thousands of year in Eastern countries. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment is the standard treatment in stage IV pulmonary adenocarcinoma patients who had tumor EGFR mutations. This...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Integr Cancer Ther
Main Authors: Hung, Hsiu-Ying, Tseng, Yen-Han, Liao, Chia-Miao, Chen, Sung-Yi, Wu, Ta-Peng, Lee, Yu-Chin, Chen, Yuh-Min
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736065/
https://ncbi.nlm.nih.gov/pubmed/27151582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735416645181
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados